A099190 Stock Overview
Engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for A099190 from our risk checks.
i-SENS, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩16,720.00 |
| 52 Week High | ₩39,700.00 |
| 52 Week Low | ₩15,500.00 |
| Beta | 0 |
| 11 Month Change | -7.27% |
| 3 Month Change | -6.33% |
| 1 Year Change | -45.63% |
| 33 Year Change | -3.77% |
| 5 Year Change | 20.72% |
| Change since IPO | 93.29% |
Recent News & Updates
i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Aug 05
i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings
Mar 27Recent updates
i-SENS, Inc. (KOSDAQ:099190) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Aug 05i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings
Mar 27Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)
May 07Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?
Mar 29Is i-SENS (KOSDAQ:099190) Using Too Much Debt?
Mar 16Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?
Mar 01Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?
Feb 14
How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?
Jan 31If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%
Jan 18Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?
Jan 05Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?
Dec 24Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 15i-SENS (KOSDAQ:099190) Could Easily Take On More Debt
Dec 02Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?
Nov 20Shareholder Returns
| A099190 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 0.6% | 0.5% | -1.0% |
| 1Y | -45.6% | 16.6% | 1.0% |
Return vs Industry: A099190 underperformed the KR Medical Equipment industry which returned 16.6% over the past year.
Return vs Market: A099190 underperformed the KR Market which returned 1% over the past year.
Price Volatility
| A099190 volatility | |
|---|---|
| A099190 Average Weekly Movement | 9.0% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A099190's share price has been volatile over the past 3 months.
Volatility Over Time: A099190's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 827 | Geun-Sig Cha | www.i-sens.com |
i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC.
i-SENS, Inc. Fundamentals Summary
| A099190 fundamental statistics | |
|---|---|
| Market cap | ₩462.04b |
| Earnings (TTM) | -₩3.53b |
| Revenue (TTM) | ₩280.29b |
1.6x
P/S Ratio-130.9x
P/E RatioIs A099190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A099190 income statement (TTM) | |
|---|---|
| Revenue | ₩280.29b |
| Cost of Revenue | ₩167.47b |
| Gross Profit | ₩112.82b |
| Other Expenses | ₩116.35b |
| Earnings | -₩3.53b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -127.77 |
| Gross Margin | 40.25% |
| Net Profit Margin | -1.26% |
| Debt/Equity Ratio | 54.7% |
How did A099190 perform over the long term?
See historical performance and comparison